Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hasan A et al. – The results suggest that retreatment with standard dose rituximab induces similar responses in 75% of previously responding patients and is well tolerated. Neither combining rituximab with CVP nor doubling the dose of rituximab increased the response rate.

Today in Coagulation/Bleeding Dz...keeping you current

A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A
International Journal of Hematology, 12/08/09

Risk factors for thrombophilia in young adults presenting with thrombosis
International Journal of Hematology, 12/08/09

Diagnosis of platelet-type von Willebrand disease by flow cytometry
Haematologica, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address